TY  - JOUR
T1  - SErotonin syndrome update
AU  - Kuehn BM
Y1  - 2011/12/28
N1  - 10.1001/jama.2011.1868
JO  - JAMA
SP  - 2661
EP  - 2661
VL  - 306
IS  - 24
N2  - 
The FDA had warned in July that linezolid (an antibiotic) or methylene blue (a drug used to treat methemoglobinemia that is also used as a marker or dye in some diagnostic procedures) can interact with drugs affecting the serotonin system. Since then, the agency learned that SSRIs and SNRIs are the psychiatric drugs most likely to trigger serotonin syndrome. The agency said it is not yet clear whether other psychiatric medications with weaker effects on the serotonin system are as likely to trigger these adverse events when used with linezolid or methylene blue.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2011.1868
UR  - http://dx.doi.org/10.1001/jama.2011.1868
ER  -